These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6709627)

  • 41. [Treatment of tuberculosis].
    Broquié G
    Soins; 1982 May; 27(9):31-4. PubMed ID: 6920111
    [No Abstract]   [Full Text] [Related]  

  • 42. Short course chemotherapy in tuberculous meningitis: a pilot trial.
    Sunakorn P; Pongparit S; Wongrung S
    J Med Assoc Thai; 1980 Jun; 63(6):340-5. PubMed ID: 7410983
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP; Ebrahim S; Pillay V
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tuberculosis].
    Bonnaud F; Zigani A
    Rev Prat; 2002 Oct; 52(16):1809-20. PubMed ID: 12564174
    [No Abstract]   [Full Text] [Related]  

  • 49. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isoniazid induced gynaecomastia: a case report.
    Garg R; Vaibhav ; Mehra S; Prasad R
    Indian J Tuberc; 2009 Jan; 56(1):51-4. PubMed ID: 19402273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.
    Bartacek A; Schütt D; Panosch B; Borek M;
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):760-6. PubMed ID: 19460254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of several immunoactive agents on the course of kidney tuberculosis].
    Bellendir EN; Nakonechnyĭ GD; Peschanskaia IN; Salmagambetov IU
    Probl Tuberk; 1976 Dec; (12):65-9. PubMed ID: 1005407
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of plasmapheresis on the course of experimental tuberculosis and the tolerance of chemotherapy by patients with renal tuberculosis].
    Bispen AV; Aleksandrova AE; Vakhmistrova TI; Vinogradova TI
    Probl Tuberk; 1992; (7-8):53-5. PubMed ID: 1488445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
    Petrova GN; Sedunova EA; Korotaeva TA
    Probl Tuberk; 1981 Mar; (3):73-4. PubMed ID: 7232397
    [No Abstract]   [Full Text] [Related]  

  • 56. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
    Toyota E; Suzuki T; Tagawa K; Takahara M; Ito M; Arai T; Kabe J; Baba H
    Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Phagocytosis in the course of tuberculosis in guinea pigs treated with isoniazid, ethambutol and capreomycin].
    Lukjan Z
    Pneumonol Pol; 1980 Jul; 48(7):461-7. PubMed ID: 6159606
    [No Abstract]   [Full Text] [Related]  

  • 58. [Duration of the treatment of tuberculosis in 1981].
    Sors C; Dautzenberg B; Grosset J
    Nouv Presse Med; 1982 Mar; 11(11):831. PubMed ID: 7070974
    [No Abstract]   [Full Text] [Related]  

  • 59. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens.
    Lambert LA; Ijaz K; Navin TR
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748
    [No Abstract]   [Full Text] [Related]  

  • 60. [Direct evaluation of the results of treatment of cutaneous tuberculosis with streptomycin, isoniazid and ethambutol].
    Arkuszewska C
    Przegl Dermatol; 1980; 67(1):97-101. PubMed ID: 7375659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.